Prophylactic infusion of allogeneic double-negative T cells as immune modulators to prevent relapse in high-risk AML patients after allo-HSCT: A phase I trial.
Xiaoyu Zhu(University of Science and Technology of China), Liming Yang(Hunan Children's Hospital), Baolin Tang(University of Science and Technology of China), Guangyu Sun(University of Science and Technology of China), Tianzhong Pan(University of Science and Technology of China), Xingchi Chen(University of Science and Technology of China), Dongyao Wang(University of Science and Technology of China), Yongsheng Han(Anhui University of Traditional Chinese Medicine), Haicun Xie, Mei‐Juan Tu(University of California, Davis)
Cited by 1
Related Papers
Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
|Nature|2000|10k
XBP1, Downstream of Blimp-1, Expands the Secretory Apparatus and Other Organelles, and Increases Protein Synthesis in Plasma Cell Differentiation
|Immunity|2004|1.1k
Blimp-1 Orchestrates Plasma Cell Differentiation by Extinguishing the Mature B Cell Gene Expression Program
|Immunity|2002|1k
RNA therapy: Are we using the right molecules?
|Pharmacology & Therapeutics|2018|172